News

Filter

Current filters:

LicensingJapan

1 to 9 of 26 results

Ono signs deal with Dako for Opdivo companion diagnostic test

Ono signs deal with Dako for Opdivo companion diagnostic test

16-02-2015

Japanese pharma company Ono Pharmaceutical and Danish diagnostic provider Dako have signed a new partnership…

BiotechnologyDakoJapanLicensingOncologyOno PharmaceuticalOpdivo

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

13-02-2015

German pharmaceuticals and chemicals major Merck KGaA is to end the co-promotion of Erbitux (cetuximab)…

Bristol-Myers SquibbErbituxJapanLicensingMerck & CoOncologyPharmaceutical

Solasia Pharma and Meiji Seika Pharma collaborate on darinaparsin

19-01-2015

Privately-held Solasia Pharma and fellow Japanese drugmaker Meiji Seika Pharma have entered into a license…

BiotechnologydarinaparsinJapanLicensingMeiji Seika PharmaOncologyResearchSolasia PharmaZiopharm Oncology

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

Kyowa Hakko Kirin to commercialize Syndax’ entinostat in Japan and Korea

08-01-2015

Shares of Japanese mid-size drugmaker Kyowa Hakko Kirin rose 3.55% to 1,138 yen by afternoon trading…

Asia-PacificentinostatJapanKyowa Hakko KirinLicensingOncologyPharmaceuticalSyndax Pharmaceuticals

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

Ariad co-opts Otsuka for Iclusig in Japan and other Asian countries

24-12-2014

US specialty pharma firm Ariad Pharmaceuticals has entered into an agreement for Japan’s Otsuka Pharmaceuticals…

Ariad PharmaceuticalsAsia-PacificBiotechnologyIclusigJapanLicensingOncologyOtsuka PharmaceuticalResearch

Anthera Pharma licenses Japan rights for blisibimod to Zenyaku Kogyo

Anthera Pharma licenses Japan rights for blisibimod to Zenyaku Kogyo

16-12-2014

US development-stage biophama company Anthera Pharmaceuticals has entered into an exclusive licensing…

AmgenAnthera PharmaceuticalsBiotechnologyblisibimodJapanLicensingOncologyZenyaku Kogyo

Daiichi Sankyo and UCB sign agreement for Vimpat in Japan

Daiichi Sankyo and UCB sign agreement for Vimpat in Japan

28-11-2014

Japanese drug major Daiichi Sankyo and Belgian drugmaker UCB have entered into an agreement to jointly…

Daiichi SankyoJapanlacosamide Tablet and InjectionLicensingNeurologicalPharmaceuticalUCBVimpat

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

29-10-2014

Netherlands-based company Qiagen has announced a master collaboration agreement with Japanese drug major…

Astellas PharmaJapanLicensingNetherlandsOncologyPharmaceuticalQiagen

1 to 9 of 26 results

Back to top